No major concerns raised by USFDA staff on Eli Lilly Alzheimer's drug Donanemab Ruchika Sharma7 Jun 2024 2:00 PM ISTLondon: FDA examination of trial data for Eli Lilly's investigational Alzheimer's drug Donanemab uncovered no red flags but did highlight safety...
Eli Lilly appoints Melissa Seymour as executive vice president of Global Quality Ruchika Sharma5 Jun 2024 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced that Melissa Seymour will join the company as executive vice president of Global Quality and member...
Aktis Oncology partners Eli Lilly to discover, develop anticancer radiopharmaceuticals Ruchika Sharma26 May 2024 11:30 AM ISTBoston: Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid...
Alonzo Weems to retire as Executive Vice President of Enterprise Risk Management, Chief Ethics and Compliance Officer: Eli Lilly Ruchika Sharma16 May 2024 1:15 PM ISTIndianapolis: Eli Lilly and Company has announced that Alonzo Weems, executive vice president of enterprise risk management and chief...
Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO Ruchika Sharma11 May 2024 11:30 AM ISTBengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their...
USFDA Advisory Committee to convene meeting to discuss on Eli Lilly Alzheimer's drug donanemab Ruchika Sharma8 May 2024 4:30 PM ISTThe U.S. Food and Drug Administration (FDA) will convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee...
Eli Lilly buys new injectable medicine manufacturing facility from Nexus Pharma Ruchika Sharma23 April 2024 12:30 PM ISTIndianapolis: Eli Lilly and Company and Nexus Pharmaceuticals, LLC have announced a definitive agreement for Lilly to acquire a manufacturing...
CDSCO Panel Approves Eli Lilly's protocol amendment proposal for Adjuvant Imlunestrant vs Standard Adjuvant study Dr. Divya Colin21 April 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
USFDA delays decision on Eli Lilly Alzheimer's drug Donanemab Ruchika Sharma10 March 2024 4:30 PM ISTWhite said the FDA wants the expert panel to discuss some of the unique aspects of the clinical trial used in its request for a traditional FDA...
Eli Lilly finds bacteria, other impurities in Mounjaro, Zepbound knockoffs Ruchika Sharma8 March 2024 5:48 PM ISTEli Lilly said on Thursday it has found bacteria and high levels of impurities in products claiming to be compounded versions of tirzepatide, the...
Eli Lilly gets CDSCO Panel Nod to Import, Market Antidiabetic Drug Tirzepatide solution for injection Single dose vial Dr. Divya Colin29 Feb 2024 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Eli Lilly expects to launch diabetes drug Mounjaro in India next year: CEO Ruchika Sharma29 Feb 2024 12:30 PM ISTMounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both conditions.
